Lucentis - AntiVEGF therapy for AMD | Private Healthcare UK
Advertisement

Lucentis - AntiVEGF therapy for AMD

Lucentis - AntiVEGF therapy for AMD

Lucentis is an AntiVEGF therapy and works by targeting abnormal retinal blood vessels, reducing or stopping the bleeding and leakage that can occur. This typically results in prevention of further loss of vision, and can also lead to improve vision. It is licensed to treat Wet AMD, Diabetic Macular Oedema, Central and Branch Retinal Vein Occlusion and Myopic CNV Degeneration. It is performed by a single injection into the eye, in a surgical clean room under a local anaesthetic.

Get a quote for lucentis - antivegf therapy for amd >

Costs and funding

Costs and funding

Lowest Average Highest
£1,385 £2,487 £3,345

Features

Latest news

Two out of five private hospitals in England do not meet safety standards intended to protect the...

Feedback from patients at BMI Three Shires Hospital in Cliftonville has shown that 99.2% of those...

Feedback from patients at BMI The Manor Hospital in Biddenham has shown that 99.0% of those who...

Find a ...

Advertisement
Advertisement
Connect with us on: